For many elderly diabetics, daily insulin injections become harder to manage with age-related cognitive decline. Missed doses ...

The Global Diabetes Devices Market is projected to expand at a compound annual growth rate (CAGR) of approximately 6% by 2026. Key drivers of this growth include the rising incidence of diabetes, ...

California has launched a program to manufacture and sell lower-cost insulin to people with diabetes. State officials say consumers will be able to purchase a five-pack of insulin pens for $55 in ...

California will start selling a generic version of glargine at a recommended price of $11 per pen, or $55 for a five-pack, January 1.

Litigation over Medtronic Plc’s alleged scheme to avoid $100 million in deal payments by sabotaging sales of a reusable ...

The state of California is teaming up with the nonprofit generic drug maker Civica Rx and Biocon Biologics to offer an interchangeable biosimilar insulin glargine pen for $11 beginning January 1, 2026 ...

This is read by an automated voice. Please report any issues or inconsistencies here. Gov. Gavin Newsom said $11 insulin pens will soon be available through the state’s pharmaceutical label.

Gov. Gavin Newsom speaks during a news conference announcing $11 insulin and prescription drugs with the CalRx program inside a Cedars-Sinai pharmacy in Los Angeles on Thursday. The effort is part of ...

Californians will be able to buy five packs of insulin pens for a maximum of $55 per pack, or $11 per pen, starting Jan. 1. The insulin is from a state-branded form of the medicine, CalRx. Lawmakers ...

California will begin selling long-acting, low-cost insulin in January, becoming the first state to bypass major pharmaceutical companies, Gov. Gavin Newsom (D-CA) announced Thursday. The move marks a ...